KMPH Gross Margin

The Gross Margin of Zevra Therapeutics Inc (KMPH) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

KMPH Gross Margin - Peers Comparison

Ticker	Name	Value
KLDO	Kaleido Biosciences Inc	7775.20%
MRK	Merck & Co Inc	80.85%
BMY	Bristol-Myers Squibb Co	75.26%
JNJ	Johnson & Johnson	69.11%
ZYNE	Zynerba Pharmaceuticals Inc	7775.20%
CTXR	Citius Pharmaceuticals Inc	7775.20%
ELOX	Eloxx Pharmaceuticals Inc	7775.20%
AGRX	Agile Therapeutics Inc	54.18%
LYRA	Lyra Therapeutics Inc	7775.20%
TFFP	TFF Pharmaceuticals Inc	7775.20%
VTRS	Viatris Inc	41.65%
WVE	WAVE Life Sciences Ltd	7775.20%
ZTS	Zoetis Inc	70.68%
ATE.TO	Antibe Therapeutics Inc	36.56%
CTLT	Catalent Inc	21.75%
ORMP	Oramed Pharmaceuticals Inc	100.00%
PFE	Pfizer Inc	74.33%
RDHL	Redhill Biopharma Ltd	47.03%
XERS	Xeris Biopharma Holdings Inc	81.86%
ELAN	Elanco Animal Health Inc	54.88%
FULC	Fulcrum Therapeutics Inc	7775.20%
CRMD	CorMedix Inc	92.66%
EYPT	EyePoint Pharmaceuticals Inc	91.42%
GRAY	Graybug Vision Inc	7775.20%
SEEL	Seelos Therapeutics Inc	80.95%
VYNE	Vyne Therapeutics Inc	93.38%
ACST.V	Acasti Pharma Inc	61.22%
CBAY	CymaBay Therapeutics Inc	7775.20%
LPCN	Lipocine Inc	7775.20%
MIST	Milestone Pharmaceuticals Inc	7775.20%
PLXP	PLx Pharma Inc	41.46%
AMPE	Ampio Pharmaceuticals Inc	7775.20%
LLY	Eli Lilly and Co	81.31%
ITRM	Iterum Therapeutics PLC	7775.20%
RPRX	Royalty Pharma PLC	7775.20%
HEPA	Hepion Pharmaceuticals Inc	7775.20%